$1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
$1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
$170萬投注於標準生物工具?看看這3只股票吧,內部人士正在積極購買。
Butterfly Network And 2 Other Stocks Under $5 Insiders Are Buying
蝴蝶網絡和其他2只股票在$5以下,內部人正在購買
The Dow Jones index closed higher by over 50 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週五收盤漲超50點。當內部人員購買或出售股票時,這表明他們對公司前景的信心或關注。對於有興趣投資或交易低價股票的投資者和交易員來說,可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是幾個近期關於低價股的值得關注的內部交易。了解更多,請查看Benzinga內幕交易平台。
Standard BioTools
標準生物工具
- The Trade: Standard BioTools Inc (NASDAQ:LAB) Director Casdin Private Growth Equity Fund, L.P. bought a total of 1,069,562 shares at an average price of $1.61. To acquire these shares, it cost around $1.72 million.
- What's Happening: On July 31, Standard BioTools reported worse-than-expected quarterly financial results and cut FY24 revenue guidance below estimates..
- What Standard BioTools Does: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster.
- 交易:Standard BioTools Inc (納斯達克:LAB) 董事Casdin Private Growth Equity Fund, L.P. 總共以1.61美元的平均價格購買了1,069,562股。要獲得這些股票,花費大約172萬美元。
- 近況:7月31日,Standard BioTools發佈了低於預期的季度財務業績,並將2024財年營業收入預期指引下調至低於市場估值。
- Standard BioTools Inc開發、製造和銷售生物醫藥研究人員快速研發藥物的技術。
Cyanotech
賽安諾科技
- The Trade: Cyanotech Corporation (OTC:CYAN) Director Michael A / Davis acquired a total of 10,000 shares at an average price of $0.73. To acquire these shares, it cost around $7,250.
- What's Happening: On Aug. 7, Cyanotech announced financial results for the first quarter of fiscal year 2025, ended June 30, 2024.
- What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.
- 交易:Cyanotech Corporation (場外交易:CYAN) 董事Michael A/Davis以0.73美元的平均價格購買了10,000股。要獲得這些股票,花費大約7,250美元。
- 近況:8月7日,Cyanotech公佈了截至2024年6月30日的2025財年第一季度財務業績。
- 賽安諾科技公司從微藻中提煉可用於營養補充劑市場的天然產品。
PHX Minerals
潘漢德爾油氣
- The Trade: PHX Minerals Inc. (NYSE:PHX) SVP – CFO Raphael D'Amico acquired a total of 3,000 shares at an average price of $3.30. The insider spent around $9,898 to buy those shares.
- What's Happening: On Aug. 12, PHX Minerals reported better-than-expected third-quarter financial results.
- What PHX Minerals Does: PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership.
- 交易:PHX Minerals Inc. (紐交所:PHX) 高級副總裁兼首席財務官Raphael D'Amico以3.30美元的平均價格購買了3,000股。內部交易者花費大約9,898美元購買這些股票。
- 近況:8月12日,PHX Minerals公佈了好於預期的第三季度財務業績。
- PHX Minerals Inc是一家擁有油氣礦產的公司,計劃將業務的核心從鑽探轉向永久礦物和天然氣所有權。
- Dow Settles Higher But Records Weekly Loss: Greed Index Remains In 'Extreme Fear' Zone
- 道瓊斯收漲,但本週下跌:貪婪指數仍處於「極度恐懼」區域。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。